China-Israel Biological Technology Joint Venture

China-Israel Biological Technology (CIBT) is a strategic joint venture established to bridge the life sciences ecosystems of China and Israel. Headquartered in the Guangzhou International Bio-Island, the company identifies innovative Israeli medical technologies and facilitates their development, clinical validation, and commercialization within the Chinese market. CIBT operates as an incubator and investment platform, managing the Guangzhou-Israel Biotech Fund (GIBF) to provide capital and infrastructure to its portfolio companies. The organization offers comprehensive support, including NMPA regulatory navigation, local manufacturing capabilities, and distribution network access. By leveraging Israeli R&D and Chinese industrial scale, CIBT accelerates the delivery of advanced healthcare solutions to patients in China.